Grantham, Mayo, Van Otterloo & Co (GMO)’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-11,170
Closed -$1.32M – 601
2016
Q4
$1.32M Sell
11,170
-9,275
-45% -$1.13M 0.01% 346
2016
Q3
$2.75M Sell
20,445
-149,842
-88% -$19.9M 0.01% 304
2016
Q2
$21.9M Buy
170,287
+17,887
+12% +$2.17M 0.09% 161
2016
Q1
$17.4M Buy
152,400
+60,600
+66% +$6.38M 0.07% 196
2015
Q4
$10.2M Sell
91,800
-10,500
-10% -$1.13M 0.04% 197
2015
Q3
$9.94M Sell
102,300
-1,002
-1% -$99.5K 0.03% 189
2015
Q2
$10M Sell
103,302
-700
-0.7% -$68.3K 0.03% 196
2015
Q1
$9.67M Sell
104,002
-1,000
-1% -$88.7K 0.03% 198
2014
Q4
$8.49M Sell
105,002
-61,464
-37% -$4.75M 0.02% 205
2014
Q3
$12.4M Buy
166,466
+27,710
+20% +$2.11M 0.03% 189
2014
Q2
$10.1M Buy
138,756
+62,902
+83% +$4.41M 0.03% 199
2014
Q1
$5.16M Buy
75,854
+70,905
+1,433% +$4.96M 0.01% 293
2013
Q4
$342K Buy
4,949
+148
+3% +$9.63K ﹤0.01% 609
2013
Q3
$287K Sell
4,801
-484
-9% -$29.8K ﹤0.01% 622
2013
Q2
$311K Buy
+5,285
New +$319K ﹤0.01% 589

Other funds holding EFX

Grantham, Mayo, Van Otterloo & Co (GMO)'s EFX Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Equifax (EFX) in Q1 2017, closing a stake of 11,170 shares — an estimated $1.32M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EFX in Q2 2013 and held it in 15 quarters. The position peaked at $21.9M in Q2 2016. 570 funds tracked by Wall St. Rank hold EFX as of Q1 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Equifax position as of Q1 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,170 Equifax shares in Q1 2017, an estimated $1.32M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Equifax in Q2 2013 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Equifax position peaked at $21.9M in Q2 2016.
  • 570 funds tracked by Wall St. Rank held Equifax as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.